Ophthalmology Times: Nov. 1, 2019
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD
2
Avisi Technologies treats first patient in SAPPHIRE trial for glaucoma
3
PainReform launches development plan for OcuRing-K, readies phase 2 trial
4
Formosa Pharmaceuticals and Rxilient sign licensing and commercialization agreement for APP13007
5
.png "Optometry Times"){kind=logo}
